Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-28544   Anthrax Lethal Factor (LF-A), Native Sequence, Recombinant from Bacillus anthracis
(Toxins)
Price: All BEI Resources products are provided
at no cost to registered researchers.
Description: Anthrax Lethal Factor (LF-A), Native Sequence, Recombinant from Bacillus anthracis
Organism: Bacillus anthracis
Biosafety Level: 1
Availability Status: In Stock
Store at: 2°C to 8°C
Contributor: BEI Resources
Comments:
Quantity limit per order for this item is 1.  This item can be ordered twice a year.  Orders over this limit will be sent to NIAID for approval before shipment.

Recombinant anthrax lethal factor (LF, 90 kDa) containing the native alanine (A) at the N-terminus was produced using a plasmid licensed from the NIH.  The lethal factor produced from this plasmid has been designated LF-A by the manufacturer. The plasmid was introduced into a non-sporulating, avirulent strain of Bacillus anthracis lacking both of the wild type plasmids, pX01 and pX02. Recombinant LF-A was purified using conventional chromatographic techniques. The resulting purified protein lacks all other anthrax virulence factors.


A recombinant form of the LF protein containing two additional amino acids at the N-terminus, a histidine (H) and a methionine (M), beyond the native N-terminal alanine (A), has been or is currently available from BEI Resources (NR-142, NR-404, NR-570, NR-723, NR-724, NR-2673, NR-4367, NR-4368). This form of the protein has been recently designated LF-HMA by the manufacturer and is also produced in Bacillus anthracis. Note: LF-A has been reported to have 3-fold higher potency than LF-HMA in cell culture cytotoxicity assays and in rat lethality studies.

LF is a zinc-dependent metalloprotease which cleaves the amino terminus of signaling proteins of the mitogen-activated protein kinase family (MAPKK), destroying their ability to signal. In vivo, recombinant LF binds to a cleaved form of recombinant protective antigen (PA), and is transported by PA into the cytosol of the macrophage where LF exerts its pathogenic effect.

Each vial contains approximately 0.1 mg (lyophilized) of recombinant LF-A from Bacillus anthracis. 

Citations: Acknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Anthrax Lethal Factor (LF-A), Native Sequence, Recombinant from Bacillus anthracis, NR-28544.”
Publications Citing
this Reagent:
Arevalo, M. T., et al. "Targeted Silencing of Anthrax Toxin Receptors Protects against Anthrax Toxins." J. Biol. Chem. 289 (2014): 15730-15738. PubMed: 24742682.
PERMITS
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top


Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.


Back to My Search